Leukemia Home > Rituxan

Rituxan is approved for the treatment of several conditions, including non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. This prescription medication is designed to kill certain cells, most notably B cells. The drug comes in injectable form, and is typically administered by a healthcare provider. Possible side effects include fever, chills, and infections.

What Is Rituxan?

Rituxan® (rituximab) is a prescription medication approved for treating the following conditions:
 

 

(Click Rituxan Uses for more information on this topic, including possible off-label uses.)
 

Who Makes Rituxan?

Rituxan is made by Genentech, Inc.
 

How Does It Work?

Rituxan is an antibody that binds to a specific antigen (known as CD20 antigen) on the surface of B cells. B cells are a type of lymphocyte (white blood cell) that plays a role in the immune system and inflammation. By binding to the CD20 antigen, Rituxan signals the body to destroy the B cells (including cancerous B cells, if the medication is being used to treat cancer).
 
Interestingly, Rituxan is made by fusing part of a mouse antibody with part of a human antibody and is grown in the ovary cells of Chinese hamsters.
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2017 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.